Latest News

Latest news from the IPHA and the international research-based pharmaceutical industry in Ireland and globally. You may subscribe to the Latest News RSS Feed here.

 

Medicines Agreement delivers value for patients and savings (03/05/2015)
“Medicines Agreement delivers value for patients and savings to the State” 700,000 patients stand to benefit from at least 29 new medicines approved in 2014

IPHA publishes revamped newsletter (02/19/2015)
In a revamped version of Medicines Matter, the newsletter of the IPHA, readers can learn about the vital role of innovative medicines in keeping Ireland’s population healthy and productive; a major new booklet on the value of the industry; a significant development in switching products to OTC status; a move towards greater transparency by the industry in its relationships with HCPs and HCOs; IPHA’s new position on biologics as well as extensive news from our member companies.

Health survey ranks Ireland top on pharmaceuticals (01/27/2015)
The annual Euro Health Consumer Index 2014 published today ranks Ireland among the best of European countries in its section on pharmaceuticals, alongside Finland, Germany, the Netherlands and the UK, England and Scotland.

Press Release - IPHA announces new chief executive (12/17/2014)
(Dublin, 17th December 2014): The Irish Pharmaceutical Healthcare Association (IPHA), representing the research-based pharmaceutical industry in Ireland, has appointed Mr Oliver O’Connor as its new Chief Executive.

Press Release - IPHA Annual Meeting highlights value of medicines to achieve healthy ageing (11/25/2014)
Tuesday, 25th November 2014: Innovative medicines play a vital role in keeping Ireland’s population healthy and productive

New publication shows value of pharmaceutical industry to patients, the health service and the economy (11/05/2014)
Wednesday, 5th November 2014: In the last ten years alone life expectancy in Ireland has gone up by four years and is now above the European average. Some of this change can be attributed to lifestyle changes; however the research shows that more than 70% of the increase can be attributed directly to innovations in modern medicines. This is one of the many pieces of data contained in ‘Bringing Health and Growth to Ireland’ a publication launched today by IPHA (the Irish Pharmaceutical and Healthcare Association) and Jerry Buttimer TD, Chairman of the Oireachtas Committee on healthcare.

Dr. Leisha Daly elected as President of IPHA (10/06/2014)
Dr Leisha Daly, Country Director of Janssen, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA).

IPHA distributes medicines.ie extract to over 9,000 healthcare professionals (09/05/2014)
Visits to mediicnes.ie website up 41% on 2013

Pharmaceutical industry welcomes move to make more medicinal products available over the counter (07/17/2014)
Thursday 17th July 2014: The Irish Pharmaceutical Healthcare Association (IPHA), which represents the international research based pharmaceutical industry in Ireland, has welcomed the publication by the Health Products Regulatory Authority (HPRA)of a list of twelve active substances (or combinations of substances) contained in medicines currently classified as prescription-only medicines (POM) which could be safely switched from POM to Over The Counter (OTC) sale (sale not subject to medical prescription).

Irish Pharmaceutical Healthcare Association looks forward to working with new Minister for Health (07/14/2014)
The Irish Pharmaceutical Healthcare Association (IPHA) which represents the international research based pharmaceutical industry in Ireland has welcomed the appointment of Mr Leo Varadkar as Minister for Health.

 

Related Content

Petri dishes
IPHA Press Releases 

IPHA is a member of -

AESGPEFPIA

For medicines and clinical trials information visit -

medicines.ieself-care.ieICTRP Portal